Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tigecycline.

× No keyword cloud information.

14 in total

1. Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium.

Authors: Vincent Cattoir; Christophe Isnard; Thibaud Cosquer; Arlène Odhiambo; Fiona Bucquet; François Guérin; Jean-Christophe Giard
Journal: Antimicrob Agents Chemother Date: 2014-10-27 Impact factor: 5.191

2. Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets.

Authors: Erik Norberg; Ana Lako; Pei-Hsuan Chen; Illana A Stanley; Feng Zhou; Scott B Ficarro; Bjoern Chapuy; Linfeng Chen; Scott Rodig; Donghyuk Shin; Dong Wook Choi; Sangho Lee; Margaret A Shipp; Jarrod A Marto; Nika N Danial
Journal: Cell Death Differ Date: 2016-10-21 Impact factor: 15.828

Review 3. Genetics of Streptomyces rimosus, the oxytetracycline producer.

Authors: Hrvoje Petković; John Cullum; Daslav Hranueli; Iain S Hunter; Natasa Perić-Concha; Jasenka Pigac; Arinthip Thamchaipenet; Dusica Vujaklija; Paul F Long
Journal: Microbiol Mol Biol Rev Date: 2006-09 Impact factor: 11.056

4. Synthesis and antibacterial activity of doxycycline neoglycosides.

Authors: Jianjun Zhang; Larissa V Ponomareva; Karen Marchillo; Maoquan Zhou; David R Andes; Jon S Thorson
Journal: J Nat Prod Date: 2013-08-29 Impact factor: 4.050

5. Methicillin-resistant Staphylococcus aureus: A public health issue with economic consequences.

Authors: Mireille Goetghebeur; Pierre-Alexandre Landry; Donald Han; Colin Vicente
Journal: Can J Infect Dis Med Microbiol Date: 2007-01 Impact factor: 2.471

Review 6. Biosensor applications in the field of antibiotic research--a review of recent developments.

Authors: Katrin Reder-Christ; Gerd Bendas
Journal: Sensors (Basel) Date: 2011-10-03 Impact factor: 3.576

7. A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia.

Authors: Gregory A Reed; Gary J Schiller; Suman Kambhampati; Martin S Tallman; Dan Douer; Mark D Minden; Karen W Yee; Vikas Gupta; Joseph Brandwein; Yulia Jitkova; Marcela Gronda; Rose Hurren; Aisha Shamas-Din; Andre C Schuh; Aaron D Schimmer
Journal: Cancer Med Date: 2016-10-13 Impact factor: 4.452

8. The hidden societal cost of antibiotic resistance per antibiotic prescribed in the United States: an exploratory analysis.

Authors: Constantinos I Michaelidis; Michael J Fine; Chyongchiou Jeng Lin; Jeffrey A Linder; Mary Patricia Nowalk; Ryan K Shields; Richard K Zimmerman; Kenneth J Smith
Journal: BMC Infect Dis Date: 2016-11-08 Impact factor: 3.090

9. A novel formulation of tigecycline has enhanced stability and sustained antibacterial and antileukemic activity.

Authors: Yulia Jitkova; Marcela Gronda; Rose Hurren; Xiaoming Wang; Carolyn A Goard; Bozhena Jhas; Aaron D Schimmer
Journal: PLoS One Date: 2014-05-28 Impact factor: 3.240

10. Antibiotic tigecycline inhibits cell proliferation, migration and invasion via down-regulating CCNE2 in pancreatic ductal adenocarcinoma.

Authors: Jie Yang; Zhen Dong; Aishu Ren; Gang Fu; Kui Zhang; Changhong Li; Xiangwei Wang; Hongjuan Cui
Journal: J Cell Mol Med Date: 2020-03-06 Impact factor: 5.310